Change over period: —
NSE · SAKAR
Sakar Healthcare Ltd
-15.0% from the 52-week high · +179.0% above the low
Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2016-10-14. The firm is engaged in providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules, vials and lyophilized injections, oral solid dosages, and research and development of these products. The Company’s products include Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin - Oral Solid and Lyophilised Injections (In Vials). The firm operates as a contract development and manufacturing organization (CDMO). The firm has approximately 321 product registrations in various countries. The manufacturing unit has been accredited by regulatory authorities of 14 countries, which includes Uganda, Kenya, Yemen, Ethiopia, Congo, Zimbabwe, Nigeria, Malawi, Philippines, Peru, Vietnam, Cote D’Ivoire.
The short version. Sakar Healthcare Ltd reported revenue of ₹87 crore for Sep 2026, up 50.0% from a year earlier. Net profit was ₹11 crore (up 120.0% year on year). Promoter holding was 51.7% in Sep 2026, down 1.88 points over 8 quarters.
1 · The price
How has the stock traded?
Sakar Healthcare Ltd trades 15.0% below its 52-week high and 179.0% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹87 cr.
Sep 2026 net profit of ₹11 cr.
5.0 pts higher than a year earlier.
Revenue compounded at 22.6% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 87 | 73 | 71 | 70 | 58 | 53 | 50 | 43 |
| Net profit | 11 | 10 | 11 | 10 | 5 | 5 | 6 | 5 |
| Net margin % | 12.9 | 14.1 | 15.5 | 14.6 | 7.9 | 8.9 | 11.5 | 10.4 |
| EPS (₹) | 5.08 | 4.62 | 4.95 | 4.61 | 2.04 | 2.1 | 2.62 | 2.06 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 252 | 178 | 153 | 133 | 128 | 95 |
| Net profit | 30 | 18 | 12 | 13 | 15 | 11 |
| Net margin % | 12.1 | 9.9 | 7.6 | 9.6 | 11.7 | 11.3 |
| EPS (₹) | 13.7 | 7.97 | 5.37 | 6.7 | 8.73 | 6.84 |
3 · The quality
How well does it turn capital into profit?
.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | — | 6.1 | 4.5 | 7.4 |
| Return on capital % | — | 8.5 | 7.1 | 8.1 |
| EBITDA margin % | 28.0 | 28.5 | 26.5 | 27.4 |
| Net margin % | 12.0 | 9.8 | 7.5 | 9.2 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 22.6% | 21.5% |
| Profit CAGR | 33.7% | 23.3% |
4 · The owners
Who holds it, and are they adding?
Down 1.88 pts over 8 quarters.
Down 1.24 pts over 8 quarters.
Up 1.04 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.58 | 53.58 | 52.86 | 52.86 | 52.86 | 52.86 | 52.52 | 51.7 | -1.88 |
| FII | 13.58 | 13.61 | 13.41 | 13.31 | 13.05 | 12.94 | 12.13 | 12.34 | -1.24 |
| DII | 10.88 | 10.97 | 11.25 | 11.43 | 11.36 | 11.32 | 11.37 | 11.92 | +1.04 |
| Public | 21.96 | 21.85 | 22.48 | 22.41 | 22.73 | 22.87 | 23.98 | 24.04 | +2.08 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for Sakar Healthcare Ltd are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about Sakar Healthcare Ltd
What is the Sakar Healthcare Ltd share price?
Sakar Healthcare Ltd (SAKAR) last closed at ₹980.75, down 2.87% on the day. Its 52-week range is ₹361.90 to ₹1,188.40.
What is the market cap of Sakar Healthcare Ltd?
Sakar Healthcare Ltd has a market capitalisation of about ₹2,247 crore. Its price-to-earnings ratio is 52.2.
How are Sakar Healthcare Ltd's latest results?
Sakar Healthcare Ltd reported revenue of ₹87 crore for Sep 2026, up 50.0% from a year earlier. Net profit was ₹11 crore (up 120.0% year on year). Promoter holding was 51.7% in Sep 2026, down 1.88 points over 8 quarters.
Who owns Sakar Healthcare Ltd?
As of Sep 2026, shareholding was: Promoter 51.7%, FII 12.34%, DII 11.92%, Public 24.04%.
How many mutual funds hold Sakar Healthcare Ltd?
0 mutual fund schemes held Sakar Healthcare Ltd in October 2026. That compares with 0 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.